100 million touched by Alzheimer's, 35 million worried. This explains some of the reasons.
clipped from www.alzheimersreadingroom.com "These studies demonstrate the potential toll Alzheimer's disease can take on patients and their families," said Michael Grundman, M.D., M.P.H., Vice President, Clinical Development, on behalf of the Alzheimer's Immunotherapy Program. "The Alzheimer's Immunotherapy Program is dedicated to advancing research and developing new treatments that may help fight this deadly disease and ease the burden on patients and their caregivers." Original content Bob DeMarco, the Alzheimer's Reading Room |
No comments:
Post a Comment